Rhythm Pharmaceuticals, Inc.
RYTM
$59.93
-$0.25-0.42%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -168.73M | -260.60M | -258.94M | -259.43M | -273.87M |
| Total Depreciation and Amortization | 1.54M | 1.56M | 1.60M | 1.65M | 1.71M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 48.85M | 134.59M | 123.65M | 126.33M | 131.83M |
| Change in Net Operating Assets | 4.85M | 10.58M | 9.28M | 3.00M | -135.00K |
| Cash from Operations | -113.49M | -113.88M | -124.42M | -128.45M | -140.47M |
| Capital Expenditure | -- | -- | 1.00K | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -53.41M | -48.17M | -46.69M | -50.83M | 5.92M |
| Cash from Investing | -53.41M | -48.17M | -46.69M | -50.83M | 5.92M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 86.48M | 56.39M | 19.25M | 64.27M | 63.20M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 138.85M | 138.85M | 138.85M | 138.85M | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.83M | -4.00M | -2.77M | 22.77M | 15.54M |
| Cash from Financing | 219.50M | 191.24M | 155.34M | 225.89M | 78.74M |
| Foreign Exchange rate Adjustments | 71.00K | 2.00K | -1.17M | -487.00K | -299.00K |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | -1.00K | -- | -- |
| Net Change in Cash | 52.67M | 29.19M | -16.94M | 46.12M | -56.10M |